Antimicrobial Resistance Spotlight
Antimicrobial Resistance
Antibiotics and similar drugs, together called antimicrobial agents, have been used for the last 70 years to treat people who have infectious diseases. Since the 1940s, these drugs have greatly reduced illness and death from infectious diseases. However, these drugs have been used so widely and for so long that the infectious organisms the antibiotics are designed to kill are adapting to them, making the drugs less effective.
Each year in the United States, at least 2 million people become infected with bacteria that are resistant to antibiotics and at least 23,000 people die each year as a direct result of these infections.
Articles
Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria
Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014
B. Fall et al. (2016 Volume 22, Number 5)
B. Fall et al. (2016 Volume 22, Number 5)
Expansion of Shiga Toxin–Producing Escherichia coli by Use of Bovine Antibiotic Growth Promoters
J. Kim et al. (2016 Volume 22, Number 5)
J. Kim et al. (2016 Volume 22, Number 5)
Fatal Septicemia Linked to Transmission of MRSA Clonal Complex 398 in Hospital and Nursing Home, Denmark
R. Nielsen et al. (2016 Volume 22, Number 5)
R. Nielsen et al. (2016 Volume 22, Number 5)
Malaria Hyperendemicity and Risk for Artemisinin Resistance among Illegal Gold Miners, French Guiana
V. Pommier de Santi et al. (2016 Volume 22, Number 5)
V. Pommier de Santi et al. (2016 Volume 22, Number 5)
Community-Associated MRSA Infection in Remote Amazon Basin Area, Peru
C. García et al. (2016 Volume 22, Number 5)
C. García et al. (2016 Volume 22, Number 5)
Technological Solutions to Address Drug-Resistant Neisseria gonorrhoeae
C. C. Bristow et al. (2016 Volume 22, Number 5)
C. C. Bristow et al. (2016 Volume 22, Number 5)
Determinants and Drivers of Infectious Disease Threat Events in Europe
J. C. Semenza et al. (2016 Volume 22, Number 4)
J. C. Semenza et al. (2016 Volume 22, Number 4)
Limited Dissemination of Extended-Spectrum β-Lactamase– and Plasmid-Encoded AmpC–Producing Escherichia coli from Food and Farm Animals, Sweden
S. Börjesson et al. (2016 Volume 22, Number 4)
S. Börjesson et al. (2016 Volume 22, Number 4)
Microevolution of Monophasic Salmonella Typhimurium during Epidemic, United Kingdom, 2005–2010
L. Petrovska et al. (2016 Volume 22, Number 4)
L. Petrovska et al. (2016 Volume 22, Number 4)
Medscape CME Activity
Shiga Toxin 1–Producing Shigella sonnei Infections, California, United States, 2014–2015
K. Lamba et al. (2016 Volume 22, Number 4)
Shiga Toxin 1–Producing Shigella sonnei Infections, California, United States, 2014–2015
K. Lamba et al. (2016 Volume 22, Number 4)
Use of Transnational Services to Prevent Treatment Interruption in Tuberculosis-Infected Persons Who Leave the United States
C. A. Tschampl et al. (2016 Volume 22, Number 3)
C. A. Tschampl et al. (2016 Volume 22, Number 3)
Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia
H. R. Stagg et al. (2016 Volume 22, Number 3)
H. R. Stagg et al. (2016 Volume 22, Number 3)
Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014
B. Henry et al. (2016 Volume 22, Number 3)
B. Henry et al. (2016 Volume 22, Number 3)
Depictions of Heroism in Battle and Anguish from Tuberculosis
T. L. Chorba and B. Breedlove (2016 Volume 22, Number 3)
T. L. Chorba and B. Breedlove (2016 Volume 22, Number 3)
Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis
J. Furin et al. (2016 Volume 22, Number 3)
J. Furin et al. (2016 Volume 22, Number 3)
Global Introduction of New Multidrug-Resistant Tuberculosis Drugs—Balancing Regulation with Urgent Patient Needs
T. Sullivan and Y. Ben Amor (2016 Volume 22, Number 3)
T. Sullivan and Y. Ben Amor (2016 Volume 22, Number 3)
Population Effects of Influenza A(H1N1) Pandemic among Health Plan Members, San Diego, California, USA, October–December 2009
R. Bitar (2016 Volume 22, Number 2)
R. Bitar (2016 Volume 22, Number 2)
Importation of Fosfomycin Resistance fosA3 Gene to Europe
A. C. Mendes et al. (2016 Volume 22, Number 2)
A. C. Mendes et al. (2016 Volume 22, Number 2)
Waterborne Elizabethkingia meningoseptica in Adult Critical Care
L. Moore et al. (2016 Volume 22, Number 1)
L. Moore et al. (2016 Volume 22, Number 1)
Rapid Emergence and Clonal Dissemination of CTX-M-15–Producing Salmonella enterica Serotype Virchow, South Korea
J. Kim et al. (2016 Volume 22, Number 1)
J. Kim et al. (2016 Volume 22, Number 1)
Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea
A. Kantele et al. (2016 Volume 22, Number 1)
A. Kantele et al. (2016 Volume 22, Number 1)
Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada
I. Martin et al. (2016 Volume 22, Number 1)
I. Martin et al. (2016 Volume 22, Number 1)
New Clinical Strain of Neisseria gonorrhoeae with Decreased Susceptibility to Ceftriaxone, Japan
T. Deguchi et al. (2016 Volume 22, Number 1)
T. Deguchi et al. (2016 Volume 22, Number 1)
Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis
A. Alanio et al. (2016 Volume 22, Number 1)
A. Alanio et al. (2016 Volume 22, Number 1)
Multiple Fungicide-Driven Alterations in Azole-Resistant Aspergillus fumigatus, Colombia, 2015
P. Le Pape et al. (2016 Volume 22, Number 1)
P. Le Pape et al. (2016 Volume 22, Number 1)
Methicillin-Resistant Staphylococcus aureus Prevalence among Captive Chimpanzees, Texas, USA, 2012
P. W. Hanley et al. (2015 Volume 21, Number 12)
P. W. Hanley et al. (2015 Volume 21, Number 12)
CTX-M-15–Producing Escherichia coli in Dolphin, Portugal
V. Manageiro et al. (2015 Volume 21, Number 12)
V. Manageiro et al. (2015 Volume 21, Number 12)
Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999–2012
L. K. Logan et al. (2015 Volume 21, Number 11)
L. K. Logan et al. (2015 Volume 21, Number 11)
USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013
M. Carrel et al. (2015 Volume 21, Number 11)
M. Carrel et al. (2015 Volume 21, Number 11)
Serotype Changes and Drug Resistance in Invasive Pneumococcal Diseases in Adults after Vaccinations in Children, Japan, 2010–2013
K. Ubukata et al. (2015 Volume 21, Number 11
K. Ubukata et al. (2015 Volume 21, Number 11
Fosfomycin Resistance in Escherichia coli, Pennsylvania, USA
H. Alrowais et al. (2015 Volume 21, Number 11)
H. Alrowais et al. (2015 Volume 21, Number 11)
RmtC and RmtF 16S rRNA Methyltransferase in NDM-1–Producing Pseudomonas aeruginosa
M. Rahman et al. (2015 Volume 21, Number 11)
M. Rahman et al. (2015 Volume 21, Number 11)
Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia
J. V. Ershova et al. (2015 Volume 21, Number 11)
J. V. Ershova et al. (2015 Volume 21, Number 11)
Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen
J. Achar et al. (2015 Volume 21, Number 11)
J. Achar et al. (2015 Volume 21, Number 11)
Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis
L. Pérez-Lago et al. (2015 Volume 21, Number 11)
L. Pérez-Lago et al. (2015 Volume 21, Number 11)
Electronic Public Health Registry of Extensively Drug-Resistant Organisms, Illinois, USA
W. E. Trick et al. (2015 Volume 21, Number 10)
W. E. Trick et al. (2015 Volume 21, Number 10)
Induction of Multidrug Tolerance in Plasmodium falciparum by Extended Artemisinin Pressure
S. Ménard et al. (2015 Volume 21, Number 10)
S. Ménard et al. (2015 Volume 21, Number 10)
Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil
D. Panesso et al. (2015 Volume 21, Number 10)
D. Panesso et al. (2015 Volume 21, Number 10)
Use of Pneumococcal Disease Epidemiology to Set Policy and Prevent Disease during 20 Years of the Emerging Infections Program
M. R. Moore and C. G. Whitney (2015 Volume 21, Number 9)
M. R. Moore and C. G. Whitney (2015 Volume 21, Number 9)
Emerging Infections Program—State Health Department Perspective
J. L. Hadler et al. (2015 Volume 21, Number 9)
J. L. Hadler et al. (2015 Volume 21, Number 9)
Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae
N. Chea et al. (2015 Volume 21, Number 9)
N. Chea et al. (2015 Volume 21, Number 9)
Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States
S. S. Magill et al. (2015 Volume 21, Number 9)
S. S. Magill et al. (2015 Volume 21, Number 9)
Emerging Infections Program as Surveillance for Antimicrobial Drug Resistance
S. K. Fridkin et al. (2015 Volume 21, Number 9)
S. K. Fridkin et al. (2015 Volume 21, Number 9)
.png)
No hay comentarios:
Publicar un comentario